They observed that complete regression of neu deletion (NDL) tumors in both treated and abscopal sites was achieved in 8 of 11 tumor bearing mice with enhanced infiltration and accumulation of CD8+ T cells in tumors. The gene discussed is CD8A; the disease is neoplasm.